Pharmacoepidemiology of testosterone prescribing in Australia, 2010-2023.

Gialouris JV, Hou W, Lim S, Handelsman DJ

Open source

DOI
10.1093/ejendo/lvag158
Published
2026 Aug 28
Container
European journal of endocrinology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ejendo/lvag158,
  title = {Pharmacoepidemiology of testosterone prescribing in Australia, 2010-2023.},
  author = {Gialouris JV and Hou W and Lim S and Handelsman DJ},
  year = {2026},
  journal = {European journal of endocrinology},
  doi = {10.1093/ejendo/lvag158},
  url = {https://doi.org/10.1093/ejendo/lvag158}
}

RIS

TY  - JOUR
TI  - Pharmacoepidemiology of testosterone prescribing in Australia, 2010-2023.
AU  - Gialouris JV
AU  - Hou W
AU  - Lim S
AU  - Handelsman DJ
PY  - 2026
JO  - European journal of endocrinology
DO  - 10.1093/ejendo/lvag158
UR  - https://doi.org/10.1093/ejendo/lvag158
ER  - 

APA

JV, G., W, H., S, L., & DJ, H. (2026). Pharmacoepidemiology of testosterone prescribing in Australia, 2010-2023.. European journal of endocrinology. https://doi.org/10.1093/ejendo/lvag158

Source records